In contrast, most T-cell lymphomas share morphological similarities and feature different frequencies of genetic alterations that either amplify the T-cell receptor signaling (e.g., NF-kB, RhoA, GATA3) or bypass it entirely (e.g., JAK/STAT, Pi3K). This evidence concerns the gene SOAT1 and T-cell non-Hodgkin lymphoma.